Navigating Policy Terrain: Perspectives for Payers on Tackling Ghost Networks
Lawmakers have ghost networks in their sights, and payers can prepare now for policy changes.
Q1 Was Pretty Good For Hospital Finance — But It’s Unclear If It Will Stay That Way
Hospitals’ operating margins and patient volumes dropped slightly in March. While hospitals were doing relatively well financially during the first quarter of the year, this new data could suggest more financial challenges ahead for hospitals. But right now, it’s unclear whether the recent declines in hospitals’ margins and volumes will be short- or long-term.
Navigating the Transition to Value-Based Care: Addressing Fears and Embracing Risk in ACO REACH
Offering blended options, individual risk pools, and net neutral capitation payments providers can embark on their journey toward value-based care at a pace aligned with their tolerance and readiness.
Amgen Puts Its Weight Behind Obesity Drug With Potential Edge Over Lilly, Novo Nordisk Meds
Amgen is confident its injectable obesity drug would have a differentiated profile compared to medications now on the market from Novo Nordisk and Eli Lilly and it’s now preparing for Phase 3 testing. But an oral obesity drug in Amgen’s pipeline will not advance beyond Phase 1.
Key Moments From the Change Healthcare Cyberattack Senate Hearing
Andrew Witty, CEO of UnitedHealth Group, faced bipartisan outrage from senators on the Senate Finance Committee angered by his company's cybersecurity failures. Here were the key moments from the hearing on Wednesday.